Revelation Biosciences (FRA:56U0) Price-to-Tangible-Book : 0.39 (As of May. 14, 2024)

View and export this data going back to 2022. Start your Free Trial

What is Revelation Biosciences Price-to-Tangible-Book?

As of today (2024-05-14), Revelation Biosciences's share price is €8.88. Revelation Biosciences's Tangible Book per Share of Dec. 2023 for the quarter that ended in Dec. 2023 was €23.04. Hence, Revelation Biosciences's Price to Tangible Book Ratio of today is 0.39.

The historical rank and industry rank for Revelation Biosciences's Price-to-Tangible-Book or its related term are showing as below:

FRA:56U0' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 0.08 Med: 2.46 Max: 4.32
Current: 0.08

During the past 4 years, Revelation Biosciences's highest Price to Tangible Book Ratio was 4.32. The lowest was 0.08. And the median was 2.46.

FRA:56U0's Price-to-Tangible-Book is ranked better than
99.67% of 1220 companies
in the Biotechnology industry
Industry Median: 2.71 vs FRA:56U0: 0.08

A closely related ratio is called PB Ratio. As of today, Revelation Biosciences's share price is €8.88. Revelation Biosciences's Book Value per Sharefor the quarter that ended in Dec. 2023 was €23.04. Hence, Revelation Biosciences's P/B Ratio of today is 0.39.

Revelation Biosciences Price-to-Tangible-Book Historical Data

The historical data trend for Revelation Biosciences's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Revelation Biosciences Price-to-Tangible-Book Chart

Revelation Biosciences Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Price-to-Tangible-Book

3.73

0.59

Revelation Biosciences Quarterly Data
	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Price-to-Tangible-Book	Get a 7-Day Free Trial							3.73	0.62	0.51	0.48	0.59

Competitive Comparison of Revelation Biosciences's Price-to-Tangible-Book

For the Biotechnology subindustry, Revelation Biosciences's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Revelation Biosciences's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Revelation Biosciences's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Revelation Biosciences's Price-to-Tangible-Book falls into.

Revelation Biosciences Price-to-Tangible-Book Calculation

Revelation Biosciences's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Dec. 2023 )
	=	8.88	/	23.044
	=	0.39

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

Revelation Biosciences Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Revelation Biosciences's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

Revelation Biosciences (FRA:56U0) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Revelation Biosciences Inc (FRA:56U0) » Definitions » Price-to-Tangible-Book

Comparable Companies

Traded in Other Exchanges

REVB:USA 56U1:Germany

Address

4660 La Jolla Village Drive, Suite 100, San Diego, CA, USA, 92122

Website

https://www.revbiosciences.com

Revelation Biosciences Inc is a clinical-stage life sciences company focused on the development of immunologic-based therapies for the prevention and treatment of disease. It has several product candidates in development. REVTx-99, the lead therapeutic candidate, is an intranasal immunomodulator to prevent or treat infections caused by various respiratory viruses such as SARS-CoV-2, including its variants, influenza A and B, parainfluenza, rhinovirus, and RSV. REVTx-99 is also being developed for other indications such as: allergic rhinitis and chronic nasal congestion. REVTx-200 is an intranasal immunomodulator adjunct to be used in combination with an intramuscular vaccination for more complete immunity. REVTx-200 is based on the same technology used in REVTx-99.

Revelation Biosciences (FRA:56U0) Headlines

No Headlines